Also, GSTO2 was a risk element for patients with COAD and COADREAD (Figures 4(q)-4(r)) and a protective factor for patients with KIRC and UVM (Figures 4(s)-4(t)). The gene discussed is GSTO2; the disease is colon adenocarcinoma.